Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex

European Journal of Pharmacology

Volumn 383, Issue 1, 1999, Pages 39-48

  Matsumoto, Machiko ^a   Togashi, Hiroko ^a   Mori, Kiyoshi ^a   Ueno, Ken ichi ^a   Miyamoto, Atsushi ^b   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT(1B) receptor; 5 HT6 receptor; Cortex, prefrontal; Dopamine release; Rat

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DOPAMINE; FLUOXETINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; ELECTROSTIMULATION; FACILITATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FLUOXETINE; MALE; MICRODIALYSIS; OLIGONUCLEOTIDES, ANTISENSE; OXADIAZOLES; PIPERAZINES; PREFRONTAL CORTEX; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0033592673     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00636-6     Document Type: Article

References (33)

1. Andersen P.H. The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:1989;493-504.
2. Benloucif S., Keegan M.J., Galloway M.P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265:1993;373-377.
3. 3 receptor in rat striatum. J. Pharmacol. Exp. Ther. 251:1989;803-809.
4. 6 receptor in the rat brain: a study using antisense oligonucleotides. J. Pharmacol. Exp. Ther. 274:1995;173-180.
5. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse. 10:1992;264-266.
6. 1D antagonist. J. Med. Chem. 37:1994;2253-2257.
7. 1B receptors. J. Pharmacol. Exp. Ther. 277:1996;823-883.
8. 1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;1-7.
9. Ennis C., Kemp J.D., Cox B. Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36:1981;1515-1520.
10. 6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse. 23:1996;164-173.
11. 6 receptor-like material in the rat central nervous system. Brain Res. 746:1997;207-219.
12. 4 receptors in guinea-pig and rat brain. Br. J. Pharmacol. 109:1993;618-624.
13. Herve D., Pickel V.M., Joh T.H., Breaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 435:1987;71-83.
14. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
15. Iyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmcological characterization. J. Pharmacol. Exp. Ther. 277:1996;40-47.
16. Jacobs B.L., Fornal C.A. Activity of brain serotonergic neurons in the behaving animal. Pharmacol. Rev. 43:1991;563-578.
17. 1B receptors block the GABA synaptic potential in rat dopamine neurons. J. Neurosci. 12:1992;2000-2006.
18. Kelland M.D., Freeman A.S., Chiodo L.A. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J. Pharmacol. Exp. Ther. 253:1990;803-811.
19. Matsumoto M., Yoshioka M., Togashi H., Mori K., Ueno K., Saito H. Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats. Eur. J. Pharmacol. 343:1998;165-170.
20. Meltzer H.Y. Role of serotonin in the action of atypical antipsychotic drugs. Clin. Neurosci. 3:1995;64-75.
21. Monsma F.J. Jr., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43:1993;320-327.
22. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271:1994;83-90.
23. Richardson B.P., Engel G., Donatsch P., Stadler P.A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature (London). 316:1985;126-131.
24. 1B/1D receptors in the modulation of 5-hyroxytryptamine levels in the frontal cortex of the conscious guinea pig. Eur. J. Pharmacol. 326:1997;23-30.
25. Roth B.L., Craigo S.C., Choudhary M.S., Uluer A., Monsma F.J. Jr., Shen Y., Meltzer H.Y., Sibley D.R. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268:1994;1403-1410.
26. 3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo. Br. J. Pharmacol. 116:1995;1545-1550.
27. 3H]dopamine. Eur. J. Pharmacol. 167:1989;309-310.
28. Siebert P.D., Larrik J.W. Competitive PCR. Nature. 359:1992;557-558.
29. 1D receptor antagonist GR 127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology. 34:1995;377-382.
30. 4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo. Br. J. Pharmacol. 117:1996;55-62.
31. Umemiya M., Berger A.J. Presynaptic inhibition by serotonin of glycinergic inhibitory synaptic currents in the rat brain stem. J. Neurophysiol. 73:1995;1192-1200.
32. 3H]dopamine by serotonin from superfused rat striatal slices. Neurosci. Lett. 28:1982;205-209.
33. 6 receptor subtype in the rat brain. Life Sci. 62:1998;1473-1477.